Clinical Trials Directory

Trials / Completed

CompletedNCT06508541

The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery

The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery: a Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
235 (actual)
Sponsor
Shanghai Tong Ren Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging

Conditions

Interventions

TypeNameDescription
PROCEDUREICG Guided surgeryIn ICG guided surgery group,Approximately 0.3 ml of ICG dissolved in 2.5 mg/ml of sterile water was injected submucosally by the endoscopic doctors through colonoscopy at two points around the tumor.All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose using ICG lymphangiography procedure
PROCEDUREconventional surgeryAll patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose

Timeline

Start date
2024-07-15
Primary completion
2024-10-01
Completion
2024-10-01
First posted
2024-07-18
Last updated
2024-12-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06508541. Inclusion in this directory is not an endorsement.